The conference will highlight the progression of discovering drug/s through highly challenging processes for establishing new chemical entities (NCEs) safety and efficacy.
Talks are deliberated by expertise involved in drug discovery process at different interfaces, namely informatics, discovery- chemistry, biology in target identification, PKPD, biomarker, and process of clinical trials.
Talks are deliberated by expertise involved in drug discovery process at different interfaces, namely informatics, discovery- chemistry, biology in target identification, PKPD, biomarker, and process of clinical trials.
